GEA, a global leader in pharma manufacturing solutions, has recently implemented a successful reorganization to increase their country-level presence both globally and across the Asia-Pacific region with the objective to ensure an increased “customer-centric focus”.
GEA is an innovative leader in automated manufacturing and processing technologies for the pharma industry – particularly in continuous manufacturing (CM). Could you please introduce the company and the advantages that CM solutions can offer pharma manufacturers?
"On the biopharma and liquid pharma front, we’ve seen huge investments in both South Korea and Singapore, where leading multinationals have financed large-scale bioprocessing facilities."
